Summary
Intuitive Surgical Inc. (ISRG) reported strong financial performance for the nine months ending September 30, 2018, demonstrating continued revenue growth driven by increased procedure volumes and robust sales of instruments and accessories. The company's strategic focus on expanding its installed base of da Vinci Surgical Systems, coupled with innovation in new product introductions like the da Vinci SP Surgical System, positions it for sustained growth. Despite increased operating expenses, particularly in research and development to fuel future innovation, the company maintained healthy profitability and generated significant cash flow from operations. From an investor's perspective, the company exhibits a healthy balance sheet with substantial cash and investment reserves, enabling continued investment in R&D and potential strategic acquisitions. The consistent growth in recurring revenue from instruments, accessories, and services further solidifies its business model. While the company faces ongoing litigation, the settlement of a significant securities class action lawsuit provides some clarity, though product liability and patent litigation remain areas to monitor.
Financial Highlights
46 data points| Revenue | $920.90M |
| Cost of Revenue | $278.60M |
| Gross Profit | $642.30M |
| R&D Expenses | $107.60M |
| SG&A Expenses | $221.40M |
| Operating Expenses | $329.00M |
| Operating Income | $313.30M |
| Net Income | $292.50M |
| EPS (Basic) | $0.86 |
| EPS (Diluted) | $0.82 |
| Shares Outstanding (Basic) | 342.00M |
| Shares Outstanding (Diluted) | 357.60M |
Key Highlights
- 1Total revenue increased by 14% to $920.9 million for the third quarter of 2018 compared to the prior year period.
- 2Instrument and accessory revenue grew by 21% to $486.3 million in Q3 2018, driven by a 20% increase in da Vinci procedures.
- 3Systems revenue saw a modest increase of 5% to $274.6 million in Q3 2018, with 231 systems shipped, up from 169 in the prior year quarter.
- 4The installed base of da Vinci Surgical Systems grew by approximately 13% year-over-year to 4,814 systems as of September 30, 2018.
- 5Net income attributable to Intuitive Surgical, Inc. for the nine months ended September 30, 2018, was $835.4 million, a significant increase from $702.4 million in the same period of 2017.
- 6The company has $4.6 billion in cash, cash equivalents, and investments as of September 30, 2018, indicating a strong liquidity position.
- 7Significant investments in Research and Development increased by 23% to $298.2 million for the nine months ended September 30, 2018, indicating a commitment to future innovation.